MGC Pharmaceuticals Limited NPV (DI) (MXC)


Pharma and Biotech

  • Change Today:
  • 52 Week High: 1.58
  • 52 Week Low: 0.53
  • Currency: UK Pounds
  • Shares Issued: 2,973.25m
  • Volume: 710,139
  • Market Cap: £17.84m
  • RiskGrade: 148

MXC Overview

MGC Pharmaceuticals Limited is a bio-pharma company with a “Nature to Medicine” strategy within the international phytocannabinoid and plant-derived medicines industry. With operations through its subsidiaries in Australia, the European Union and the UK (the “Group”), the Company is developing phytocannabinoid-derived and plant-derived medicines as well as unique formulations, both proprietary and for third parties, all to GMP standard.

Key Personnel

Independent Non-Executive Director: Ross Walker
Managing Director and CEO: Roby Zomer
Non-Executive Chairman: Brett Mitchell
Senior Independent Director: Stephen Parker
Non-Executive Dir: Nativ Segev

Contact Details

Address: 1202 Hay Stree, West Perth, Australia, WA 6005
Phone: +61 (8)6382 3390


Sector: Pharma and Biotech(LSE)
ISIN: AU000000MXC6

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.


MXC Market Data

Currency UK Pounds
Share Price 0.60p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.58
52 Week Low 0.53
Volume 710,139
Shares Issued 2,973.25m
Market Cap £17.84m
RiskGrade 148

MXC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

MXC Dividends

No dividends found

Trades for 07-Feb-2023

Time Volume / Share Price
16:14 307 @ 0.65p
16:12 7,721 @ 0.65p
15:54 70 @ 0.65p
15:54 13,654 @ 0.65p
15:54 306 @ 0.55p

Top of Page